DIN 02464713 — PROCYSBI 75 MG
PROCYSBI is a capsule (delayed-release) of Cysteamine marketed by AMGEN CANADA INC. The full Cysteamine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02464713
- Brand name
- PROCYSBI
- Active ingredient
- Cysteamine
- Strength
- 75 MG
- Dosage form
- CAPSULE (DELAYED-RELEASE)
- Route
- ORAL
- Manufacturer
- AMGEN CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Cystine-depleting agent (ophthalmic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cysteamine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02485605 | CYSTADROPS | 0.37 % | SOLUTION | RECORDATI RARE DISEASES CANADA INC | MARKETED |
| 02464705 | PROCYSBI | 25 MG | CAPSULE (DELAYED-RELEASE) | AMGEN CANADA INC | MARKETED |